BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 10835101)

  • 1. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
    Griffioen AW; Molema G
    Pharmacol Rev; 2000 Jun; 52(2):237-68. PubMed ID: 10835101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms and factors of angiogenesis].
    Poveshchenko AF; Konenkov VI
    Usp Fiziol Nauk; 2010; 41(2):68-89. PubMed ID: 20469605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential factors associated with hepatic angiogenesis.
    Das SK; Vasudevan DM
    Life Sci; 2007 Nov; 81(23-24):1555-64. PubMed ID: 17950364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotherapeutics from natural products: from bench to clinics?
    Bernas G
    Clin Hemorheol Microcirc; 2003; 29(3-4):199-203. PubMed ID: 14724342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiogenesis in solid tumours: an overview.
    Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
    Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical perspective of angiogenesis inhibitors].
    Radema SA; Witteveen PO; Gebbink MB; Voest EE
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis.
    Schoettler N; Brahn E
    Curr Opin Investig Drugs; 2009 May; 10(5):425-33. PubMed ID: 19431075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of angiogenesis and cancer.
    Tonini T; Rossi F; Claudio PP
    Oncogene; 2003 Sep; 22(42):6549-56. PubMed ID: 14528279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding angiogenesis and its clinical applications.
    Suh DY
    Ann Clin Lab Sci; 2000 Jul; 30(3):227-38. PubMed ID: 10945562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis as an immunopharmacologic target in inflammation and cancer.
    Bian XW; Chen JH; Jiang XF; Bai JS; Wang QL; Zhang X
    Int Immunopharmacol; 2004 Nov; 4(12):1537-47. PubMed ID: 15351323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic cancer therapy.
    Cao Y
    Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
    Morabito A; Sarmiento R; Bonginelli P; Gasparini G
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E; Taher A
    J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-based molecules in angiogenesis.
    D'Andrea LD; Del Gatto A; Pedone C; Benedetti E
    Chem Biol Drug Des; 2006 Feb; 67(2):115-26. PubMed ID: 16492159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
    Van Langendonckt A; Donnez J; Defrère S; Dunselman GA; Groothuis PG
    Mol Hum Reprod; 2008 May; 14(5):259-68. PubMed ID: 18430758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.